Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
5.64 USD | -0.70% | -5.84% | +15.34% |
17/05 | Oppenheimer Initiates Capricor Therapeutics at Outperform Rating | MT |
13/05 | Transcript : Capricor Therapeutics, Inc., Q1 2024 Earnings Call, May 13, 2024 |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+15.34% | 18Cr | |
+15.55% | 12TCr | |
+12.66% | 11TCr | |
-2.53% | 2.48TCr | |
+1.14% | 2.25TCr | |
-9.35% | 1.83TCr | |
-42.28% | 1.63TCr | |
-18.92% | 1.53TCr | |
+6.19% | 1.41TCr | |
+28.83% | 1.17TCr |
- Stock Market
- Equities
- CAPR Stock
- News Capricor Therapeutics, Inc.
- Transcript : Capricor Therapeutics, Inc., Q2 2021 Earnings Call, Aug 12, 2021